Illumina (ILMN) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Illumina (ILMN) over the last 10 years. The current PE ratio for Illumina as of May 22, 2018 is 56.18.
|Medical||Medical - Biomedical and Genetics||$39.808B||$2.752B|
|Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.|